Magnetic Iron Oxide Nanoparticles Show Promise In Cancer Therapy

Iron oxide nanoparticles (INOPs) are promising for carrying cancer drugs that target specific tissues. Iron oxides are widespread in nature and can be synthesized in the laboratory. Hematite, magnetite and maghemite nanoparticles have particularly promising properties for biomedical applications.

Recent studies on the preparation, structure and magnetic properties of IONPs were reviewed by researchers in China and Korea. The researchers emphasized that the size, size distribution (the relative proportions of different-sized particles in a given sample), shape and magnetic properties of IONPs affect the location and mobility of IONPs in the human body. Controlling the shape and size distribution of magnetic IONPs is a challenge.

‘When the size of the body changes, the different regions and cells within the organs respond differently.’

Magnetic IONPs are promising for carrying cancer drugs that target specific tissues when they are coated with a biocompatible shell that carries a specific drug. If the IONPs are too large, it may be cleared from the blood stream. The researchers found that controlling the size of these particles with diameters ranging from 10 to 100 nanometres are optimal for intravenous injection and can remain in the bloodstream for the longest period of time.

The surface charge of IONPs is also important for their stability and how they interact with tissues. For instance, breast cells take up positively charged IONPs better than negatively charged ones. However, positively charged IONPs are more rapidly cleared from the circulation. Negatively charged and neutral IONPs tend to remain longer in the circulation.

The surface charge of IONPs can be controlled by using an appropriately charged functionalized material as a shell. Other applications that can benefit from improving the functionality of magnetic IONPs include magnetic resonance imaging, magnetic hyperthermia and thermoablation (killing selected cancer cells with heat), and biosensing (detecting molecular interactions for disease diagnosis).

The researcher team will be focussing on fabricating recyclable magnetic IONP catalysts and designing multifunctional biomedical applications, involving magnetic IONPs, that can play a dual role in diagnosing and treating disease, says Professor Wei Wu from China's Wuhan University.

The review is published in the journal Science and Technology of Advanced Materials.

Source: Medindia